PGNX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Progenics Pharmaceuticals Inc's other expenses for the three months ended in Sep. 2014 was $-4.04 Mil. Its other expenses for the trailing twelve months (TTM) ended in Sep. 2014 was $-16.08 Mil.
Other Expenses incurred by banks.
Progenics Pharmaceuticals Inc Other Expenses for the trailing twelve months (TTM) ended in Sep. 2014 was -3.624 (Dec. 2013 ) + -4.034 (Mar. 2014 ) + -4.389 (Jun. 2014 ) + -4.037 (Sep. 2014 ) = $-16.08 Mil.
Progenics Pharmaceuticals Inc Annual Data
Progenics Pharmaceuticals Inc Quarterly Data